Literature DB >> 17092675

[Assessment, triage, and follow-up of a patient with: acute CAP COPD].

K Faure1.   

Abstract

The purpose of this review was to analyze the literature concerning community-acquired pneumonia (CAP) and acute exacerbations of chronic obstructive pulmonary disease (AECOPD) published in the last five years. CAP and AECOPD are frequent diseases that are to this day still associated with high morbidity and mortality rates. Patient management, especially the choice of the management environment, outpatient or intensive care, depends on the knowledge and recognition of predictors of complications, mortality risk factors, and severity signs to the extent that predictive algorithms have been established. However, research and publications concerning discharge criteria and follow-up of CAP and AECOPD patients is more sparse.

Entities:  

Mesh:

Year:  2006        PMID: 17092675      PMCID: PMC7133787          DOI: 10.1016/j.medmal.2006.07.011

Source DB:  PubMed          Journal:  Med Mal Infect        ISSN: 0399-077X            Impact factor:   2.152


  224 in total

1.  Variation in management of community-acquired pneumonia requiring admission to Alberta, Canada hospitals.

Authors:  Y Jin; T J Marrie; K C Carriere; G Predy; C Houston; K Ness; D H Johnson
Journal:  Epidemiol Infect       Date:  2003-02       Impact factor: 2.451

2.  Medium-term survival after hospitalization with community-acquired pneumonia.

Authors:  Grant W Waterer; Lori A Kessler; Richard G Wunderink
Journal:  Am J Respir Crit Care Med       Date:  2003-12-23       Impact factor: 21.405

3.  Using randomized controlled trial data, the agreement between retrospectively and prospectively collected data comprising the pneumonia severity index was substantial.

Authors:  Drahomir Aujesky; Roslyn A Stone; D Scott Obrosky; Donald M Yealy; Thomas E Auble; Thomas P Meehan; Louis G Graff; Jonathan M Fine; Michael J Fine
Journal:  J Clin Epidemiol       Date:  2005-04       Impact factor: 6.437

4.  Impact of influenza vaccination on seasonal mortality in the US elderly population.

Authors:  Lone Simonsen; Thomas A Reichert; Cecile Viboud; William C Blackwelder; Robert J Taylor; Mark A Miller
Journal:  Arch Intern Med       Date:  2005-02-14

Review 5.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

6.  Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity.

Authors:  M Ruiz; S Ewig; M A Marcos; J A Martinez; F Arancibia; J Mensa; A Torres
Journal:  Am J Respir Crit Care Med       Date:  1999-08       Impact factor: 21.405

7.  Cardiac troponin I in patients with severe exacerbation of chronic obstructive pulmonary disease.

Authors:  Christophe Baillard; Mohamed Boussarsar; Jean-Philippe Fosse; Emmanuelle Girou; Philippe Le Toumelin; Christophe Cracco; Samir Jaber; Yves Cohen; Laurent Brochard
Journal:  Intensive Care Med       Date:  2003-02-13       Impact factor: 17.440

Review 8.  Exacerbations of chronic obstructive pulmonary disease.

Authors:  Jadwiga A Wedzicha; Gavin C Donaldson
Journal:  Respir Care       Date:  2003-12       Impact factor: 2.258

9.  Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study.

Authors:  G Rohde; A Wiethege; I Borg; M Kauth; T T Bauer; A Gillissen; A Bufe; G Schultze-Werninghaus
Journal:  Thorax       Date:  2003-01       Impact factor: 9.139

Review 10.  Respiratory rehabilitation after acute exacerbation of COPD may reduce risk for readmission and mortality -- a systematic review.

Authors:  Milo A Puhan; Madlaina Scharplatz; Thierry Troosters; Johann Steurer
Journal:  Respir Res       Date:  2005-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.